Fürstner Alois
Acc Chem Res. 2021 Feb 16;54(4):861-874. doi: 10.1021/acs.accounts.0c00759. Epub 2021 Jan 28.
Macrocyclic natural products are plentiful in the bacteria, archaea, and eukaryote domains of life. For the significant advantages that they provide to the producing organisms, evolution has learned how to implement various types of macrocyclization reactions into the different biosynthetic pathways and how to effect them with remarkable ease. Mankind greatly benefits from nature's pool, not least because naturally occurring macrocycles or derivatives thereof serve as important drugs for the treatment of many serious ailments.In stark contrast, macrocyclization reactions are usually perceived as difficult to accomplish by purely chemical means. While it is true that ring closure necessarily entails an entropic loss and may result in the buildup of (considerable) ring strain that must be compensated for in one way or the other, it is also fair to note tremendous methodological advances during the last decades that greatly alleviated this traditional "macrocycle challenge". It is therefore increasingly possible to explore the advantages provided by large as well as medium-size ring systems in a more systematic manner. This venture also holds the promise of increasing the "chemical space" amenable to drug development to a considerable extent.In consideration of this and other important long-term perspectives, it is appropriate to revisit the current state of the art. To this end, a number of vignettes are presented, each of which summarizes a total synthesis project targeting macrocyclic natural products of greatly different chemotypes using a variety of transformations to reach these goals. Although we were occasionally facing "dead ends", which are also delineated for the sake of a complete picture, these case studies illustrate the notion that the formation of a certain macrocyclic perimeter is (usually) no longer seriously limiting. In addition to substantial progress in the "classical" repertoire (macrolactonization and macrolactamization (pateamine A, spirastrellolide, and belizentrin)), various metal-catalyzed reactions have arguably led to the greatest leaps forward. Among them, palladium-catalyzed C-C bond formation (roseophilin and nominal xestocyclamine A) and, in particular, alkene and alkyne metathesis stand out (iejimalide, spirastrellolide, enigmazole, ingenamine, and sinulariadiolide). In some cases, different methods were pursued in parallel, thus allowing for a critical assessment and comparison.To the extent that the macrocyclic challenge is vanishing, the opportunity arises to focus attention on the postmacrocyclization phase. One may stipulate that a well-designed cyclization precursor does not only ensure efficient ring closure but also fosters and streamlines the steps that come after the event. One way to do so is dual (multiple) use in that the functional groups serving the actual cyclization reaction also find productive applications downstream from it rather than being subject to simple defunctionalization. In this context, better insight into the conformational peculiarities of large rings and the growing confidence in their accessibility in a stereochemically well defined format rejuvenate the implementation of transannular reactions or reaction cascades that can lead to rapid and substantial increases in molecular complexity. The examples summarized herein showcase such possibilities, with special emphasis on tranannular gold catalysis and the emerging ruthenium-catalyzed -hydrometalation chemistry for the selective functionalization of alkynes.
大环天然产物在细菌、古菌和真核生物生命域中大量存在。由于它们为产生这些物质的生物体提供了显著优势,进化过程已经学会如何在不同的生物合成途径中实现各种类型的大环化反应,并且能够极其轻松地实现这些反应。人类从大自然的宝库中受益匪浅,尤其是因为天然存在的大环化合物或其衍生物是治疗许多严重疾病的重要药物。
与之形成鲜明对比的是,大环化反应通常被认为很难通过纯粹的化学方法来完成。诚然,环化必然会导致熵的损失,并且可能会产生(相当大的)环张力,而这种环张力必须以某种方式得到补偿,但同样值得注意的是,在过去几十年中,方法学取得了巨大进展,极大地缓解了这一传统的“大环挑战”。因此,越来越有可能以更系统的方式探索大环和中环体系所提供的优势。这一探索也有望在很大程度上扩大适合药物开发的“化学空间”。
考虑到这一点以及其他重要的长期前景,重新审视当前的技术水平是恰当的。为此,本文介绍了一些实例,每个实例都总结了一个全合成项目,该项目使用各种转化方法来合成化学类型差异很大的大环天然产物以实现这些目标。尽管我们偶尔会遇到“死胡同”,为了全面呈现情况也会对其进行描述,但这些案例研究表明,形成特定的大环周长(通常)不再是严重的限制因素。除了在“经典”方法(大环内酯化和大环内酰胺化(如帕替胺A、螺旋星孢菌素和贝利森曲林))方面取得的重大进展外,各种金属催化反应无疑带来了最大的飞跃。其中,钯催化的碳 - 碳键形成(玫瑰红素和名义上的西托环胺A),特别是烯烃和炔烃复分解反应尤为突出(如伊吉马利德、螺旋星孢菌素、谜唑、英格胺和西努拉二内酯)。在某些情况下,可以并行采用不同的方法,从而进行关键的评估和比较。
在大环挑战逐渐消失的程度上,有机会将注意力集中在大环化后阶段。可以推测,精心设计的环化前体不仅能确保高效的环化,还能促进并简化环化之后的步骤。一种方法是进行双重(多重)利用,即用于实际环化反应的官能团在环化反应之后也能有富有成效的应用,而不是简单地进行官能团消除。在这种背景下,对大环构象特性的更深入了解以及对以立体化学明确的形式获得大环的信心不断增强,使得跨环反应或反应级联的实施得以复兴,这些反应或级联可以迅速且大幅提高分子复杂性。本文总结的实例展示了这些可能性,特别强调了跨环金催化以及新兴的钌催化的炔烃氢金属化化学用于炔烃的选择性官能化。